Low-dose doxycycline (Oracea) for rosacea

Medical Letter on Drugs and Therapeutics

Volumn 49, Issue 1252, 2007, Pages 5-6

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BISMUTH SALICYLATE; CARBAMAZEPINE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; IRON; METRONIDAZOLE; PHENYTOIN; PROTON PUMP INHIBITOR; RIFAMPICIN; WARFARIN; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; FOOD DRUG INTERACTION; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PAPULE; PERIODONTITIS; PHOTOSENSITIVITY; PUSTULE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SHORT SURVEY; VAGINA CANDIDIASIS; ADULT; ARTICLE; DRUG INTERACTION; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG INTERACTIONS; HUMANS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; ROSACEA;

EID: 33846934515     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. FC Powell. Clinical practice. Rosacea. N Engl J Med 2005; 352:793.
2. Drugs for acne, rosacea and psoriasis. Treat Guidel Med Lett 2005; 35:49.
3. AN Sapadin and R Fleischmajer. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54:258.
4. J Del Rosso and J Bikowski. Multicenter, double-blind, randomized, placebo-controlled, parallel-group trial results evaluating the effects of 40 mg doxycycline monohydrate controlled-release capsules in treatment of rosacea. J Am Acad Dermatol 2006; 54 (3) suppl:AB30, abstract P164.
5. JB Bikowski. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed 2003; 2:234.
6. B Berman and D Zell. Subantimicrobial dose doxycycline: a unique treatment for rosacea. Cutis 2005; 75 suppl 4:19.
7. J Sanchez et al. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 2005; 53:791.
8. C Walker and G Webster. A multicenter, double-blind, randomized trial to evaluate long-term anti-inflammatory dose doxycycline (40 mg) therapy: results of the lack of effect on bacterial flora. Poster presented at the Fall Clinical Dermatology Conference, Las Vegas, Nevada, October 6-9, 2006.